Company information

<p> Revenues of the pharmaceutical division grew by 3.6%, driven by the immunology ($13.95bn) and oncology ($10.69bn) portfolio. Some of the new prescription drugs approved during the year included BALVERSA™ (erdafitinib), XARELTO® (rivaroxaban), SPRAVATO® (esketamine), INVOKANA® (canagliflozin) and STELARA® (ustekinumab).</p> <p> J&J expects minor disruption to its pharmaceutical business in 2020 although growth is projected to remain above market growth. The majority of the categories of the consumer health segment are anticipated to perform well, although certain categories may be impacted due to reduced store visits and social distancing behaviours.</p> <p> J&J is working towards the development of a COVID-19 vaccine through the Ad26® vector technology and PER.C6® manufacturing platform. </p>

Product Description

Made from a unique formula and has been used throughout the world for nearly 60 years, It Is Pure In Colour, Pleasant In Odour, It Is Mild Yet Suitable For Use By Both Adults And Children, Relief Of Giddiness, Headaches, Travel Sickness, Stomach-Ache, Insect Bites, Rheumatic Pain, Muscular Pain, Blocked Nose And Cold, For Quick Relief Of Cold & Headache